---

Related Articles:

Enhanced in vitro CA1 network activity in a sodium channel β1(C121W) subunit model of genetic epilepsy.

2014-04-01

[Epilepsia 55(4) , 601-8, (2014)]

Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel.

2013-11-01

[Expert Opin. Drug Saf. 12(6) , 847-55, (2013)]

Ezogabine (retigabine) and its role in the treatment of partial-onset seizures: a review.

2012-09-01

[Clin. Ther. 34(9) , 1845-56.e1, (2012)]

[Retigabine - a new antiepileptic drug with a different mechanism of action].

2013-01-01

[Postepy. Hig. Med. Dosw. 67 , 973-81, (2013)]

P-retigabine: an N-propargyled retigabine with improved brain distribution and enhanced antiepileptic activity.

2015-01-01

[Mol. Pharmacol. 87(1) , 31-8, (2015)]